Styrene monooxygenases (SMOs) can catalyze the asymmetric epoxidation of alkenes to obtain optically active epoxides. This account describes a series of work of our group on the isolation, application, and improvement of an SMO from Pseudomonas sp. LQ26. The strain was isolated from an active sludge sample based on indigo-forming capacity. Then the gene encoding SMO was expressed in Escherichia coli, and the whole cells were applied in biocatalytic reactions. The substrate spectrum of SMO was successfully expanded from conjugated styrene derivatives to non-conjugated alkenes, especially α-substituted secondary allylic alcohols, affording enantiopure epoxides. Most significantly, cascade reactions involving ketoreductase and SMO were designed, which resulted in glycidol derivatives or epoxy ketones with excellent enantio-and diastereo-selectivity using α,β-unsaturated ketones as the substrates. In addition, mutants of SMO with altered substrate preference and enhanced activity were constructed, which indicated great potential of SMO for further improvement.
Background
Enantiopure epoxides are extremely versatile building blocks in organic synthesis and pharmaceutical industry (Lin et al. 2011a; Sharpless 2002) . Although numerous chemo-catalyzed asymmetric epoxidations have been developed in the last few decades, biocatalytic epoxidation serves as a strong candidate for preparing single enantiomeric epoxides, especially starting from nonfunctional terminal alkenes. Several kinds of enzymes, such as styrene monooxygenase (SMO), xylene monooxygenase (XMO), alkene/alkane monooxygenase, chloroperoxidase, etc., have been reported to catalyze asymmetric epoxidation. Among them, SMOs (EC 1.14.14.11) display exceptional enantioselectivity that is very attractive for preparing single enantiomeric epoxides (Bernasconi et al. 2000; Lin et al. 2010 Lin et al. , 2011a Schmid et al. 2001) .
SMOs catalyze the transformation of styrene into (S)-styrene oxide in the upper metabolic pathway of styrene degradation (Mooney et al. 2006) . They are mostly twocomponent flavin-dependent monooxygenase composed of a FAD-dependent styrene epoxidase and a NADHdependent flavin reductase (StyB), encoded by styA and styB genes (Otto et al. 2004) . Besides the two-component SMOs, several self-sufficient one-component SMOs have been isolated from Rhodococcus opacus (Tischler et al. 2012) , and a novel styrene monooxygenase SmoA isolated from metagenome as well (Van Hellemond et al. 2007 ). Most SMOs reported so far originate from Pseudomonas and Rhodococcus species, sharing high sequence similarities (Bae et al. 2010; Lin et al. 2010; Mooney et al. 2006; Otto et al. 2004; Toda et al. 2012) .
When overexpressed in Escherichia coli, SMOs are able to catalyze the epoxidation of styrene to afford (S)-styrene epoxide with >99 % ee (Bernasconi et al. 2000; Otto et al. 2004) . Particularly, the SMO from Pseudomonas taiwanensis VLB120 (Volmer et al. 2014 ) has been successfully scaled up in the production of enantiopure (S)-styrene oxide (Panke et al. 2002) . Further investigation Open Access *Correspondence: wuzhl@cib.ac.cn 1 Key Laboratory of Environmental and Applied Microbiology, Chengdu Institute of Biology, Chinese Academy of Sciences, 9 South Renmin Road, 4th Section, Chengdu 610041, Sichuan, People's Republic of China Full list of author information is available at the end of the article has expanded its substrate spectrum to styrene derivatives and analogs (Lin et al. 2011c; Liu et al. 2015) , as well as aliphatic olefins (Toda et al. 2015) . Compared with classic chemo-catalysts and hydrolytic kinetic resolution to achieve optically pure styrene oxide, SMO catalyzes the epoxidation of styrene and derivatives with exquisite regio-and enantioselectives under moderate reaction conditions, providing an attracting alternative for the synthesis of chiral epoxides (Bernasconi et al. 2000; Lin et al. 2010; Schmid et al. 2001) .
This account focuses on the continuous effort of our research group on the isolation, application, and improvement of an SMO from Pseudomonas sp. LQ26. The work began with the traditional isolation of microorganism from environmental samples, and led to some interesting discoveries to synthesize chiral epoxides with varied structures that have expanded the scope of bioepoxidation reactions.
Isolation of styrene upper catabolic genes from Pseudomonas sp. LQ26
The styrene degrading strain was isolated by plating a styrene-enriched active sludge sample on agar plates containing 4-chloroindole based on the known indigoforming capacity of SMOs (Panke et al. 1998; Van Hellemond et al. 2007 ). The compound 4-chloroindole had been used in our previous work in the directed evolution of cytochrome P450 2A6, and proved a better substrate than indole for library screening because of enhanced color development (Zhang et al. 2009 ). The strain was designated Pseudomonas sp. LQ26 based on 16s rDNA analysis. It was able to use styrene and styrene oxide as sole carbon sources, and its SMO activity was inducible by the addition of styrene (Lin et al. 2010) .
The styAB gene of Pseudomonas sp. LQ26 showed a maximum of 79 % sequence identity with other styABs. It appeared as the most distant member of all SMOs originating from the genus of Pseudomonas (Lin et al. 2010) . Genomic walking upstream and downstream of styAB gene of Pseudomonas sp. LQ26 revealed the same arrangement of open reading frames (ORF) as described before for the styrene upper catabolic pathway (Mooney et al. 2006) , with two regulatory genes styS and styR upstream, encoding a sensor histidine kinase and a response regulator, and two additional styrene catabolic genes styC and styD downstream encoding a styrene oxide isomerase and a phenylacetaldehyde dehydrogenase.
The comparison of individual styrene catabolic ORFs from Pseudomonas sp. LQ26 with others in the genus of Pseudomonas is shown in Table 1 . The sizes of the six genes (styS, styR, styA, styB, styC, styD) were the same as previously reported (The 7641-bp genomic sequence of stySRABCD has been deposited at GeneBank under accession no. GU593979). Their identities ranged from 72 to 80 % at DNA level and 80-91 % at protein level. The sequence alignments demonstrated that each gene in the styrene catabolism upper pathway in Pseudomonas sp. LQ26 was the most distant member of all originating from the genus of Pseudomonas, and the conserved operonic structure suggested a common evolutionary origin for this catabolic cluster.
Asymmetric epoxidation of styrene derivatives and analogs
The isolated styAB gene of Pseudomonas sp. LQ26 was expressed in recombinant E. coli, and the whole cells harboring the SMO were applied to the epoxidation of a spectrum of styrene derivatives and analogs in a bis(2-ethylhexyl) phthalate (BEHP)/aqueous biphasic system, which is known to facilitate in situ product extraction and substrate supply to alleviate the product/substrate inhibition (Panke et al. 2002) .
The results showed that the SMO could catalyze the epoxidation of a broad range of conjugated aromatic alkenes with varied skeletons, affording the corresponding (S)-epoxides with excellent enantiomeric excesses (>99 %) at up to 100 % conversions (Fig. 1) . However, electron-withdrawing group and bulky groups appeared unfavorable for the reaction. Bromo-and chlorosubstituted substrates afforded lower product yields. Bulky alkenes such as (E)-stilbene, or compounds with electron-withdrawing group directly connected to the terminal alkene, such as (E)-4-phenylbut-3-en-2-one, (E)-1-(3-chloroprop-1-enyl) benzene, and (E)-1-(2-nitrovinyl)benzene were not accepted as substrates of the SMO (Lin et al. 2010 (Lin et al. , 2011b . Furthermore, the bio-epoxidation of a series of styrene derivatives with substituents ranging from H to propyl demonstrated a significant steric effect (Table 2) . Substituents at the R 3 position appeared to be unfavorable in all the cases tested. Substrates with a bulky substituent apparently showed lower activities. Substituents at the α-position (R 1 ) caused greater steric hindrance than those at the β-position (R 2 ), and the (E)-isomers of substituent R 2 = Et and R 2 = n-pr performed much better than the corresponding (Z)-isomers (Table 2) (Lin et al. 2011b ).
Asymmetric epoxidation of allylbenzene derivatives
The SMO from Pseudomonas sp. LQ26 was found to catalyze the epoxidation of non-conjugated alkenes, yielding the corresponding (S)-epoxides with low to moderate enantiomeric excesses (Fig. 2) (Lin et al. 2010) . Despite the low selectivity, this is the first report on the epoxidation of non-conjugated alkenes catalyzed by SMO. For the substrate 1-allylbenzene, the bio-epoxidation yielded product with 36 % ee. A recent report also showed that the SMOs from Rhodococcus sp. ST-5 and ST-10 catalyzed the same substrate to the corresponding epoxides with 76.2 and 65.7 % ee, respectively (Toda et al. 2012) .
Inspired by the positive impact of the hydroxyl group to the chiral recognition (Fig. 2) , we subsequently applied the SMO to the kinetic resolution of α-substituted secondary allylic alcohols, and achieved excellent enantio-and diastereo-selectivity, generating a spectrum of glycidol derivatives with contiguous stereogenic centers (Table 3 ; Fig. 3a ) (Lin et al. 2011c) . In all cases, (S)-allylic alcohols were the preferred enantiomers to undergo the epoxidation, which is consistent with the selectivity of SMO towards conjugated styrene derivatives. Over 99 % enantiomeric excesses were achieved in most cases with varied reactivity and diastereomeric ratio. The biotransformation was greatly affected by the position of the substituents. Substituents at ortho-positions strongly prevented the reaction with no epoxide formation observed for o-fluoro-or o-methyl-substituted substrates. Electron-withdrawing groups also negatively impacted the reactivity (Table 3 , entries 2-7). Table 3 Comparison of two methods in the production of chiral glycidol derivatives a The schemes for Methods 1 and 2 are shown in Fig. 3 . Briefly, Method 1 uses racemic allylic alcohols as the substrates and recombinant E. coli BL21 cells expressing SMO as the catalyst, and the reactions continue for 2-48 h at 30 °C. Method 2 uses α,β-unsaturated ketones as the substrates. The bioreduction of ketones was first performed in the presence of both ChKRED03 and the GDH/glucose system. Then freshly harvested whole cells of recombinant E. coli expression SMO were added, and the incubation was continued at 30 °C for 2-36 h b Determined via reverse-phase HPLC analysis, and defined as (moles of product formed)/(moles of total added substrate) Fig. 3 Production of chiral glycidol derivatives using the a one-step strategy involving the whole cells of recombinant E. coli expressing SMO or the b two-step strategy involving the additional use of ChKRED03 and GDH For racemic 1-phenylprop-2-enol (Entry 1), the product (1R, 2R)-phenyl glycidol was achieved in 2 h with excellent enantioselectivity (ee > 99 %) and diastereoselectivity (dr 98:2) at the maximum theoretical yield of 50 %. The remaining (R)-isomer was recovered with >99 % ee without further transformation. The result showed clear advantage of the enzymatic method over previously established chemistry methods, such as the Sharpless epoxidation and vanadium-based method (Zhang et al. 2005) , which required up to 12 days for the same substrate to reach 50 % conversion, and yielded the epoxide with 90-93 % ee.
Cascade reactions involving SMO and ketoreductase
In order to overcome the low theoretical yield of kinetic resolution of secondary allylic alcohols, we designed a one-pot two-step enzymatic cascade starting from prochiral α,β-unsaturated ketones using an S-specific ketoreductase ChKRED03 and SMO (Fig. 3b) . ChKRED03 was a putative ketoreductase mined from the genome of Chryseobacterium sp. CA49 (Liu et al. 2014) . In this cascade reaction, ChKRED03 performed the efficient bioreduction of the substrates to provide (S)-allylic alcohols in the presence of the GDH-catalyzed NADPH recycling system, followed by SMO-catalyzed epoxidation to achieve glycidol derivatives (Fig. 3b) . Excellent enantioselectivity (>99 % ee) and diastereoselectivity (dr > 99:1) were achieved for the majority of the substrates, and the product yields reached up to >99 % (Table 3) . Compared with previous results using SMO as the only catalyst, the two-step enzymatic cascade delivered much improved substrate conversion and product yield. The isolated yields reached up to 93 % in a 50-ml reaction system (Table 3) .
For α,β-unsaturated ketones, the C=C double bond can undergo either reduction or epoxidation. The former reaction was undesired in this case, but often proceeded efficiently in the presence of E. coli whole cells. Therefore, we performed the knockout of the nemA gene (encoding N-acetyl maleimide reductase) from E. coli BL21 (DE3). The resulting strain of E. coli BL21ΔnemA showed significantly decreased ene-reductase activity toward 4-phenylbut-3-en-2-one (Liu and Wu 2016) . When the carbonyl reductase READH and SMO were co-expressed in such a strain, the whole-cell system enabled a "formal" asymmetric bio-epoxidation of electron-deficient (substituted)-4-phenylbut-3-en-2-one via a tandem reduction-epoxidation-dehydrogenation cascade (Fig. 4a) , yielding chiral epoxy ketones with up to >99 % ee and >99 % conversion. In the presence of excess amount of isopropanol, the main product was literally switched from epoxy ketones to allylic epoxy alcohols with excellent enantio-and diastereo-selectivity and high yield (Fig. 4b) (Liu and Wu 2016) , which serve as extremely versatile intermediates with further functionalization (Hussain and Walsh 2008; Lauret 2001) .
Protein engineering of SMO
Rational design was employed to engineer the SMO from Pseudomonas sp. LQ26 based on the X-ray crystal structure of the dimeric FAD-specific oxygenase subunit (StyA) of the SMO from P. putida S12 (PDB ID: 3IHM) Fig. 4 Enzymatic cascade for the asymmetric epoxidation of α,β-unsaturated ketones to generate a epoxy ketones or b allylic epoxy alcohols. The reactions were catalyzed with the whole cells of recombinant E. coli BL21ΔnemA coexpressing SMO and READH (Ukaegbu et al. 2010) , which shares 89 % identity at the protein level. Using molecular docking, three mutants (Y73 V, Y73F, and S96A) being adjacent to the phenyl ring of styrene have been found to exhibit higher enzymatic activities than the wild-type in the epoxidation of styrene, while retaining excellent stereoselectivity. The specific epoxidation activity of the most active mutant S96A toward styrene and trans-β-methylstyrene are 2.6-and 2.3-fold of the wild-type, respectively. In addition, the Y73V mutant showed an unexpected reversal of enantiomeric preference toward 1-phenylcyclohexene (Lin et al. 2012) . Sequence alignment shows that all SMOs originating from the genus Pseudomonas share the same amino acid residues at positions 73 and 96. However, self-sufficient one-component StyA2B from R. opacus 1CP has Ile and Ala at the corresponding positions, respectively (Tischler et al. 2012 ), but whether they would indicate higher activity in StyA2B is currently unknown (Lin et al. 2012) .
Molecular docking of α-ethylstyrene was also performed to identify adjacent residues, and four amino acid substitutions (R43A, L44A, L45A, and N46A) were introduced into the enzyme, leading to a change of substrate preference. The mutant L45A, in particular, exhibited an altered substrate preference toward the bulkier substrate α-ethylstyrene (Qaed et al. 2011 ).
Conclusion and perspective
SMO-catalyzed bio-epoxidation reactions possess great potential for green synthesis. They utilize molecular oxygen as a clean reactant, and are routinely carried out at ambient temperature under atmospheric pressure, delivering chiral epoxides with exceptionally high chem-, regio-, and stereo-selectivity in most cases. However, many challenges remain, such as insufficient enzyme availability, narrow substrate spectrum, poor stability, and low catalytic efficiency. Our efforts on the SMO from Pseudomonas sp. LQ26 indicated that the substrate spectrum of SMO could be expanded by elaborative substrate design and protein engineering. The current investigation is focused on exploiting new "epoxygenase" and designing downstream enzymatic reactions to use the epoxides in situ, which is expected to lead to more diversified products.
